Skip to main content
SpringerLink
Log in

Hypoxia in Solid Tumours and Normal Tissues: Clinical Implications

  • Chapter
Radiation Oncology: Radiobiological and Physiological Perspectives

Part of the book series: Developments in Oncology ((DION,volume 60))

  • 120 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 259.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 329.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 329.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Source Material And Selected Further Reading

The Oxygen Effect, Acute and Chronic Hypdxia

  1. Brown JM (1979) Evidence of acutely hypoxic cells in mouse tumours, and a possible mechanism of reoxygenation. Br J Radiol 52: 650–656.

    Article  PubMed  CAS  Google Scholar 

  2. Chapman DJ, Durand RE, Olive PL (1986) Acute hypoxia: implications for modifiers of radiation effects. Int J Radiat Oncol Biol Phys 12: 1279–1283.

    Article  Google Scholar 

  3. Franco AJ, Sutherland RM (1979) Radiation survival of cells from spheroids grown in different oxygen concentrations. Radiat Res 78: 454–464.

    Article  Google Scholar 

  4. Hall E (1988) The oxygen and reoxygenation. In: Radiobiology for the radiologist. JB Lippincott Co Philadelphia pp. 137–160.

    Google Scholar 

  5. Moore JV (1983) Cytotoxic injury to cell populations of solid tumours. In: Cytotoxic insult to tissue- Effects on cell lineages. Eds: CS Potten and JH Hendry Churchill Livingstone Edinburgh pp. 368–403.

    Google Scholar 

  6. Sutherland RM, Frank AJ (1980) On the nature of the radio-biologically hypoxic fraction. Int J Radiat Oncol Biol Phys 6: 117–120.

    Article  PubMed  CAS  Google Scholar 

  7. Thomlinson RH (1977) Hypoxia and tumours. J Clin Path (Suppl) 11: 105–113.

    Article  CAS  Google Scholar 

Measurement of Oxygen Tension in Tumours

  1. Badib AO, Webster JH (1969) Changes in tumour oxygen tension durin radiation therapy. Acta Radiol 8: 247–257.

    Article  CAS  Google Scholar 

  2. Bergsjo P, Evans JC (1968) Tissue oxygen tension during radiation therapy. Acta Radiol 7: 1–11.

    CAS  Google Scholar 

  3. Cater DB, Silver IA (1960) Quantitative measurements of oxygen tension in normal tissues and in tumours of patients before and after radiotherapy. Acta Radiol 53: 233–256.

    Article  PubMed  CAS  Google Scholar 

  4. Jypg H (1983) Radiation effects on tumours/review. Proceedings 7 International Congress of Radiation Research Reviews and Summaries. Eds: JJ Broerse, GW Barendsen, HB Kal and AJ van der Kogel Martinus Nijhoff Publishers Amsterdam Dl-R pp 427–434.

    Google Scholar 

  5. Kolstad P (1963) Vascularization, oxygen tension, and radio-curability in cancer of the cervix. Norwegian monograms on

    Google Scholar 

  6. medical science. Scandinavian University Books. Universitetsforlaget.

    Google Scholar 

  7. Mueller-Klieser W, Vaupel P, Manz R (1983) Tumour oxygenation under normobaric and hyperbaric conditions. Br J Radiol 56: 559–564.

    Article  PubMed  CAS  Google Scholar 

Tumours Vasculature As An Index Of Hypdxia In Human Tumours (Mostly Cancer Cervix)

  1. Awwad HK, El-Naggar M, Mocktar N. Barsoum M (1986) Intercapillary distance measurement as an indicator of hypoxia in carcinoma of the cervix uteri. Int J Radiat Oncol Biot Phys 12: 1329–1333.

    Article  CAS  Google Scholar 

  2. Kolstad P (1968) Intercapillary distance, oxygen tension and local recurrence in cervix cancer. Scand J Clin Lab Invet 22: 106–112.

    Google Scholar 

  3. Siracka E, Siracky J, Pappova N, Revesz L (1982) Vascularization and radiocurability in cancer of the uterine cervix, a retrospective study. Neoplasma 29: 183–188.

    PubMed  CAS  Google Scholar 

Anaemia: Animal Experiments (General Reviews Stressing Adaptive Processes, Mathematical Modelling)

  1. Degner FL, Sutherland RM (1986) Theoretical evaluation of expected changes in oxygenation of tumours associated with different hemoglobin levels. Int J Radiat Oncol Biol Phys 12: 1291–1294.

    Article  PubMed  CAS  Google Scholar 

  2. Hirst D (1986) Anemia: a problem or an opportunity in radiotherapy? Int J Radiat Oncol Biol Phys 12: 2009–2017.

    Article  PubMed  CAS  Google Scholar 

  3. Hirst D, Wood PJ (1987) The adaptive response of mouse tumours to anaemia and retransfusion. Int J Radiat Biol 51: 597–609.

    Article  CAS  Google Scholar 

  4. Hirst DG, Hazlehurst JL, Brown MJ (1984) The effect of alterations in haematocrit on tumour sensitivity to X-rays. Int J Radiat Biol 46: 345–354.

    Article  CAS  Google Scholar 

  5. Siemann DW, Hill RP, Bush RS, Chhabra P (1979) The in vivo radiation response of an experimental tumour: The effect of exposing tumour-bearing mice to a reduced oxygen environment prior to but not during irradiation. Int J Radiat Oncol Biol Phys 5: 61–68.

    Google Scholar 

Anaemia: Clinical Studies (Including Influence of Arterial Oxygen Content and Effect on Normal Tissues)

  1. Bush RS (1984) Current status of treatment of localized disease and future aspects. Int J Radiat Oncol Biol Phys 10: 1165–1174.

    Article  PubMed  CAS  Google Scholar 

  2. Bush RS, Jenkin RDT, Allt WEC, Beale FA, Bean H, Dembo AJ, Pringle JF (1978) Definite evidence for hypoxic cells influencing cure in cancer therapy. Br J Cancer 37 (Suppl III): 302–306.

    Google Scholar 

  3. Dische S, Anderson PJ, Sealy R, Watson ER (1983) Carcinoma of cervix-anaemia, radiotherapy and hyperbaric oxygen. Br J Radiol 56: 251–255.

    Article  PubMed  CAS  Google Scholar 

  4. Dische S, Saunders MI, Warburton MF (1986) Hemoglobin, radiation, morbidity and survival. Int J Radiat Oncol Biol Phys 12: 1335–1337.

    Article  PubMed  CAS  Google Scholar 

  5. Overgaard J, Hansen HS, Jorgensen K, Hansen HM (1986) Primary radiotherapy of larynx and pharynx carcinoma-an analysis of some fators influencing local control and survival. Int J Radiat Oncol Biol Phys 12. 515–421.

    Article  PubMed  CAS  Google Scholar 

  6. Rustowski J, Kupsc W (1982) Factors influencing the results of radiotherapy in case of inoperable endometrial cancer. Gynecol Oncol 14: 185–193.

    Article  PubMed  CAS  Google Scholar 

  7. Sasai K, Ono K. Hiraoka M, Tsutsui K, Takahashi M, Abe M (1989) Effect of arterial oxygen content on the result of radiation therapy for bronchogenic carcinoma. Int J Radiat Oncol Biol Phys (In press).

    Google Scholar 

  8. Quilty P, Duncan W (1986) The influence of hemoglobin level on the regression and long term local control of transitional cell carcinoma of the bladder following photon therapy. Int J Radiat Oncol Biol Phys 12: 1735–1742.

    Article  PubMed  CAS  Google Scholar 

Hyperbaric Oxygen Clinical Trials

  1. Henk JM (1986) Late results of trial of hyperbaric oxygen and radiotherapy in head and neck cancer: A radionale for hypoxic cell sensitizers? Int J Radiat Oncol Biol Phys 12: 1339–1341.

    Article  PubMed  CAS  Google Scholar 

  2. Henk JM, Sith CW (1977) Radiotherapy and hyperbaric oxygen in head and neck cancer. Interim report of the second trial. Lancet ii: 104–105.

    Google Scholar 

  3. Watson EL, Halnan KE, Dische S, Saunders MI, Cade IS, McEwen JB, Wiernik G, Perrins DJD, Sutherlands I (1978) Hyperbaric oxygen and radiotherapy: a Medical Research Council trial in carcinoma of the cervix. Br J Radio 51: 879–887.

    Article  CAS  Google Scholar 

Measurement 31 Hypdxic Cells (3H-Misonidazole, 19F-MISO Analogues, P-MRS, NMR, Tumours pH, Hypoxic Cell Markers)

  1. Brown TR (1989) The predictive possibilities for NMR in oncology. In: Prediction of tumour treatment response. Eds: JD Chapman LJ Peters HR Withers Pergamon Press NY pp. 297–306.

    Google Scholar 

  2. Hlatky L, Hong C, Sachs R (1988) An intrinsic marker for hypoxia. 6th Conference on: Chemical modifiers of cancer treatment. Paris Abstract 1–9.

    Google Scholar 

  3. Hlatky L, Ring C. Sachs RK (1989) Comparison of 3-H-misonidazole binding between CHO and 9L cells using the sandwich system. Int J Radiat Oncol Biol Ph.vs 16: 943–94 947.

    Google Scholar 

  4. Koutcher JA, Okunieff P, Neuringer L, Suit H, Brady T (1987) Size dependent change in tumour p3fiosphate metabolism after radiation therapy as detected by P NMR spectroscopy. In J Radiat Oncol Biol Phys 13: 1851–1855.

    Google Scholar 

  5. Miraldi F (1986) Potential of NMR and PET for determining tumour metabolism. Int J Radiat Oncol Biol Phys 12: 1033–1039.

    Article  PubMed  CAS  Google Scholar 

  6. Ng TC, Evanchko WT, Kiramoto RN, Ghanta VI(3i Lilly MB, Lawson AJ, Corbet TH, Durant JR, Glickson JD (1982) P NMR spectroscopy

    Google Scholar 

  7. Raleigh JA, Franko AJ, Trimble LA. Allen PS (1988) Development of a 19-F magnetic resonance spectroscopy method for measuring oxygen deficiency in tumor tissue. 6th Conference on: Chemical modifiers in cancer treatment. Paris Abstract 1–2. Phys (In press).

    Google Scholar 

  8. Wike-Hooley JL, Haveman J, Reinhold HS (1984) The relevance of tumour pH to the treatment of malignant disease. Radiother Oncol 2: 343–366.

    Article  PubMed  CAS  Google Scholar 

  9. Urtasun RC, Chapman JA, Raleigh JA, Franko AJ, Koch CJ, KcKinnon S (1989) Measurement of the hypoxic fraction in solid human tumours utilizing 14C-misonidazole binding In vivo“ technique. 6th conference on:Chemicalmodifiers in cancer treatment.Paris Abstract 1–10.

    Google Scholar 

Hypdxia In Normal Tissues

  1. Hendry JH (1979) Quantitation of the radiotherapeutic importance of naturally hypoxic normal tissues from collated experiments with rodents using single doses. Int J Radiat Oncol Biol Phys 5: 971–979.

    Article  PubMed  CAS  Google Scholar 

  2. Travis E (1984) The oxygen dependence of protection by amino-thiols: implications for normal tissues and solid tumours. Int J Radiat Oncol Biol Phys 10: 1495–1501.

    Article  PubMed  CAS  Google Scholar 

Prefluorochemical (Experimental, Toxicity in Man, Clinical Studies)

  1. Fedor EJ, Wisdom C, Lowe N (1989) Clinical safety of Fluosol DA 20% An oxygen carrier for radiosensitization. Int J Radiat Oncol Biol Phys (In press).

    Google Scholar 

  2. Goodman RL, Moore RE, Davis ME, Stokes D, Yuhas JM (1984) Perfluorocarbon emulsions in cancer therapy: preliminary observations on presently available formulations. Int J Radiat Oncol Biol Phys 10: 1421–1424.

    Article  PubMed  CAS  Google Scholar 

  3. Lartigau E, Thomas CH, La Blanc M, Reiss J, Long D, Long C, Malaise EP, Guishard M (1989) New high oxygen carrying perfluorochemical emulsions: toxicity, radiosensitivity of GM-CFC and development of metastases in mice. Int J Radiat Oncol Biol Phys (In press).

    Google Scholar 

  4. Martins DF, Porter EA, Rockwell S, Fischer JJ (1987) Enhancement of tumour radiation response by the combination of a perfluorochemical emulsion and hyperbaric oxygen.

    Google Scholar 

  5. Rose C, Lustig R, McIntosh N, Teicher B (1986) A clinical trial of Fluosol DA 20% in advanced squamous cell carcinoma of the head and neck. Int J Radiat Oncol Biol Phys 12: 1325–1327.

    Article  PubMed  CAS  Google Scholar 

  6. Song CW, Zhang WL, Pence DM, Lee I, Seymour HL (1985) Increased sensitivity of tumours by perfluorochemicals and carbogen. Int J Radiat Oncol Biol Phys 11: 1833–1836.

    Article  PubMed  CAS  Google Scholar 

  7. Thomas Ch, Lartigau L, Malaise EP, Guichard M (1989) New high oxygen-carrying perfluorochemical emulsions and/or carbogen reactions of a human tumour xenograft to irradiation. Int J Radiat Oncol Biol Phys (In press).

    Google Scholar 

  8. West L, McIntosh N, Gendler S, Seymour C, Wisdom C (1986) Effects of intravenously infused Fluosol-DA 20% in rats. Int J Radiat Oncol Biol Phys 12: 1319–1323.

    Article  PubMed  CAS  Google Scholar 

Hyporic Cell Radiosensitizers: General Properties and Pharmacorinetics

  1. Adams GE (1973) Chemical sensitization of hypoxic cells. Br Med Bull 29: 48–53.

    PubMed  CAS  Google Scholar 

  2. Adams GE, Clarke ED, Flockhart IR, Jacobs RG, Smithen CE (1979) Structure-activity relationships in the development of hypoxic cell radiosensitizers. I. Sensitization efficiency. Int J Radiat Biol 35: 133–150.

    Google Scholar 

  3. Adams GE, Clarke ED, Gray P, Jacobs RS, Stratford IJ, Wardman P, Watts ME, Patrick J, Wallace RG, Smithen CE (1979) Structure-activity relationships in the development of hypoxic cell radiosensitizers. II. Cytotoxicity and therapeutic ratio. Int J Radiat Biol 35: 151–160.

    Google Scholar 

  4. Adams G, Stratford IJ (1988) Radiation sensitizers and related compounds: new approaches to modification of radiation response. In: Radiobiology in Radiotherapy. Ed: NM Bleehen Springer-Verlag London pp. 153–164.

    Google Scholar 

  5. Ash DV, Peckham MJ, Steel GG (1979) The quantitative response of human tumours and misonidazole. Br J Cancer 40: 883–889.

    Article  PubMed  CAS  Google Scholar 

  6. Brown JM (1984) Electron-affinic agents: Development of the optimum radiosensitizer and chemosensitizer for clinical application. In: Modification of radiosensitivity in cancer treatment. Ed: T Sugahara Academic Press Tokyo pp. 139–178.

    Google Scholar 

  7. Coleman CN (1985) Hypoxic cell radiosensitizers: expectations and progress in drug development. Int J Radiat Oncol Biol Phys 11: 323–329.

    Article  PubMed  CAS  Google Scholar 

  8. Denekamp J (1980) Testing of hypoxic cell radiosensitizers in vivo Cancer Clin Trials 3: 139–148.

    CAS  Google Scholar 

  9. Dische S (1988) Radiation sensitizers in clinical radiotherapy. In: Radiobiology in radiotherapy. Ed: NM Bleehen Springer-Verlag London pp. 165–175.

    Google Scholar 

  10. Fowler JF, Denekamp J (1979) A review of hypoxic cell radiosensitization in experimental tumours. Pharmacol Ther 7: 413–444.

    Article  PubMed  CAS  Google Scholar 

  11. Hill RP (1986) Sensitizers and dose fraction: results and interpretations Int J Radiat Oncol Biol Phys 12: 1049–1054.

    Article  CAS  Google Scholar 

  12. Rauth AM (1984) Pharmacology and toxicology of sensitizers: mechanism studies. Int J Radiation Oncol Biol Phys 10: 1293–1300.

    Article  CAS  Google Scholar 

  13. Workman P (1980) Pharmacokinetics of hypoxic cell radiosensitizers A review Cancer Clin Trials 3: 237–251.

    CAS  Google Scholar 

Misonidazole: Results Of Clinical Trials (Reviews)

  1. Awwad HK, El Badawy S, Ghoneim M, Barsoum M, Zaghloul M, Akoush H, Abou Zaid M, Osman A, El Naggar M (1987) Experience in the use of hypoxic cell chemical radiosensitizers and the potential use of some newer drugs. In: Radiotherapy in developing countries. International Atomic Energy Agency Vienna pp. 281–289.

    Google Scholar 

  2. Dische S (1985) Chemical sensitizers for hypoxic cells. A decade of experience in clinical radiotherapy (Review). Radiother Oncol 3: 97–116.

    Article  PubMed  CAS  Google Scholar 

  3. Urtasun RC, Coleman CN, Wasserman TH, Philips TL (1984) Clinical trials with hypoxic cell sensitizers: time to retrench or time to push forward? Int J Radiat Oncol Biol Phys 10: 1691–1696.

    Article  PubMed  CAS  Google Scholar 

Miso Trial With Positive Results

  1. Baillet F, Housset M, Dessard-Diana B, Boisserie G (1989) Positive clinical experience with misonidazole in brachytherapy and external radiotherapy. Int J Radiat Oncol Biol Phys 16: 1073–1076.

    Article  PubMed  CAS  Google Scholar 

  2. Overgaard J, Hansen HS, Andersen AP, Hjelm-Hansen M. Jorgensen K, Sandberg E,Berthelsen A.Hanmer R, Pedersen,M (1989) Misonidazole combined with split-course radiotherapy in the treatment of invasive carcinoma of the larynx and pharynx. Final report from DAHANCA 2 study. Int J Radiat Oncol Biol Phys 16: 1065–1068.

    CAS  Google Scholar 

Topical use of Radiosensitizers

  1. Awwad HK, Abd El Moneim H, Abd El Baki H, Omar S, El Merzabani M, Farag H (1983) The topical use of misonidazole in bladder cancer. In: progress in clinical and biological research volume 132D 13t International Cancer Congress, Part D Research and Treatment. Eds: EA Mirand, WB Hutchinson E Mihish Alan R.Liss Inc NY pp. 305–316.

    Google Scholar 

  2. Balmukhanov SB, Beisebaev AA, Aitkoolova ZI, Mustaphin JS, Philippenko VI, Rismuhamedova RS, Aisarova AM, Abdrahmanov JN, Revesz L (1989) Intratumeral and paremetrial infusion of metronidazole in the radiotherapy of uterine cervix cancer. Int J Radiat Oncol Biol Phys 16. 1061–1063.

    Article  PubMed  CAS  Google Scholar 

  3. Sealy R, Cridland S, Blekkenhorst G, Barry L, Rombouts T (1988) Interstitial misonidazole: clinical experience in advanced mouth cancer. Clin Radiol 39: 182–185.

    PubMed  CAS  Google Scholar 

Etanidazole (SR-2508)

  1. Awwad HK, El Badawy S, Zagloul MS, Osman M, Abd El Baki H, Fairchild K (1989) Pharmacokinetics of SR-2508 (Etanidazole) in bladder and cervical cancer: evidence for diffusion from urine. Int J Radiat Oncol Biot Phys 16: 1083–1084.

    Article  CAS  Google Scholar 

  2. Brown JM, Yu NY, Brown DM, Lee • WW (1981) SR-2508: a 2-nitroimidazole amide which should be superior to misonidazole as a radiosensitizer for clinical use. Int J Radiat Oncol Biol Phys 7: 695–703.

    Article  PubMed  CAS  Google Scholar 

  3. Coleman CN, Wasserman TH, Urtasun J, Halsey J, Hirst VK, Hannock S, Philips TL (1986) Phase I trial on the hypoxic cell radiosensitizer SR 2508: the results of the five to six weeks drug schedule. Int J Radiat Oncol Biol Phys 12: 1105–1108.

    Article  PubMed  CAS  Google Scholar 

Pimonidazole (RO-03-8799)

  1. Dische S, Saunders MI, Bennett, Dunphy EP, Des Rochers C (1986) A comparison of the tumour concentrations obtainable with misonidazole and Ro-03–8799 Br J Radiol 59: 911–917

    CAS  Google Scholar 

  2. Laurent F, Canal P, Soula G (1989) Pharmacokinetics of Ro-03–8799 in mice bearing melanosarcoma. Comparison with tumours without melanin. Int J Radiat Oncol Biol Phys 16: 1101–1104.

    Google Scholar 

  3. Lespinasse F, Thomas Ch, Bonney M, Malaise EP, Guichard M (1989) Ro-03–8799 preferential relative uptake in human tumour xenografts compared to a murine tumour? Comparison with SR-2508. Int J Radiat Oncol Biol Phys 16: 1105–1110

    Article  PubMed  CAS  Google Scholar 

  4. Roberts JT, Bleehen NM, Walton MI, Workman P (1986) A clinical phase I toxicity study of Ro-03–8799: plasma, urine, tumour and normal brain pharmacokinetics. Br. J. Radiol 59: 107–116.

    Google Scholar 

Mixed Function Radiosensitizers

  1. Adams GE, Ahmed I, Sheldon PW, Stratford IJ (1984) Radiation sensitization and chemosensitization: RSU-1069 a compound more effective than misonidazole in vitro and in vivo. Br J Cancer 49: 571–577.

    Article  PubMed  CAS  Google Scholar 

  2. Ahmed I, Jenkins TC, Walling JM, Stratford IJ, Sheldon PW, Adams GE, Fielden EM (1986) Analogues of RSU-1069: Radiosensitization and toxicity in vitro and in vivo. Int J Radiat Oncol Biol Phys 12: 1079–1082.

    Google Scholar 

  3. Chaplin DJ, Acker B (1987) The effect of hydralazine on the tumour cytotoxicity of the hypoxic cell cytotoxin RSU-1609: evidence for therapeutic gain. Int J Radiat Oncol Biol Phys 13: 579–585.

    Article  PubMed  CAS  Google Scholar 

Combination of Sensitizing Agents

  1. Bleehen NM, Newman HVF, Maughan TS, Workman P (1989) A multidose study of the combined radiosensitizers Ro-8799 (pimonidazole) and SR-2508 (etanidazole). Int J Radiat Oncol Biol Phys 16: 1093 - I096.

    Article  PubMed  CAS  Google Scholar 

  2. Dische S, Saunders MI, Dunphy EP, Bennet MH, DesRochers C. Stratford MRL, Minchiniton AI, Orchard RA (1986) Concentrations achieved in human tumours after administration of misonidazole and Ro-03–8799. Int J Radiat Oncol Biol Phys 12: 1109–1112.

    Article  PubMed  CAS  Google Scholar 

  3. Sealy R, Cridland S, Barry L, Norris R (1986) Irradiation with misonidazole and hyperbaric oxygen: final report on a randomized trial in advanced head and neck cancer. Int J Radiat Oncol Phys 12: 1343–1346.

    Article  CAS  Google Scholar 

Cellular Glutathione, Chemosensitization and Radiosentitization

  1. Biaglow E, Epp E (1983) The role of thiols in cellular response to radiation and drugs. Radiat Res 95: 437–455.

    Article  PubMed  CAS  Google Scholar 

  2. Clark EP, Epp E, Biaglow JE, Norse-Gaudio M, Zachgo E (1984) Glutathione depletion, radiosensitization, and misonidazole potentiation in hypoxic Chinese hamster ovary cells by buthionine sulfoximine. Radiat Res 98: 370–380.

    Article  PubMed  CAS  Google Scholar 

  3. Mitchell JB, DeGraff W, Gamson J, Russo A (1989) Evaluation of nitroimidazole hypoxic cell radiosensitizers in a human tumour cell line high in intracellular glutathione. Int J Radiat Oncol Radiol 16: 1021–1024.

    Article  Google Scholar 

  4. Mitchell JB, Russo A (1987) The role of glutathione in radiation and drug cytotoxicity. Br J Cancer 55 (Suppl VII): 96–104.

    CAS  Google Scholar 

  5. Mitchell JB, Russo A, Carmichael J, Glatstein E (1989) Glutathione as a predictor of tumour response. In: Prediction of tumour treatment response. Eds: JD Chapman, LJ Peters, HR Withers Pergamon Press NY pp. 157–174.

    Google Scholar 

  6. Russo A, Charmichael J, Friedman N, DeGraff W, Tochner Z, Glastein E, Mitchel JB (1986) The role of intracellular glutathione in antineoplastic chemotherapy. Int J Radiat Oncol Biol Phys 12: 1347–1354.

    Article  PubMed  CAS  Google Scholar 

Chemosensitization by Hypdxic Cell Sensitizers

  1. Bleehen NM, Freedman L, Stenning S (1989) Phase 3 studies of CCNU with or without benznidazole for recurrent gliomas. Int J Radiat Oncol Biol Phys 16: 1077–1081.

    Article  PubMed  CAS  Google Scholar 

  2. Bleehen NM, Roberts JT (1986) A phase II study of CCNU and benznidazole for metastatic malignant melanoma. Int J Radiat Oncol Biol Phys 12: 1401–1404.

    Article  PubMed  CAS  Google Scholar 

  3. Grau C, Zachariae C, Mao N, Overgaard J (1989) Cytotoxic effect of radiation, misonidazole and cyclophosphamide on aerobic and hypoxic cells in a C3H mammary carcinoma in vivo. Int J Radiat Oncol Biol Phys (In press).

    Google Scholar 

  4. Glover D, Trump D, Kvols L, Elso P, Vogl S (1986) Phase II trial of misonidazole (MISO) and cyclophosphamide ( CYC) in metastatic renal cell carcinoma. Int J Radiat Oncol Biol Phys 12: 1405–1408.

    Google Scholar 

  5. Hinchcliffe M, McNally NJ (1984) A comparison of the ability of some radiosensitizers undergoing clinical trials to act as chemosensitizers. Int J Radiat Oncol Biol Phys 10: 1635–1640.

    Article  Google Scholar 

  6. Lee FYF, Workman P (1984) Nitroimidazoles as modifiers of nitosourea pharmacokinetics 10: 1627–1630.

    CAS  Google Scholar 

  7. Ling LI, Streffer C, Sutherland R (1986) Decreased hypoxic toxicity and binding of misonidazole by low glucose concentration. Int J Radiat Oncol Biol Phys 12: 1231–1234.

    Article  PubMed  CAS  Google Scholar 

  8. Roberts TJ, Bleehen NM, Workman P, Walter MI (1984) A phase

    Google Scholar 

  9. I study of the combination of benznidazole and CCNU in man. Int J Radiat Oncol Biol Phys 10: 1745–1748.

    Google Scholar 

  10. Siemann DW (1984) Modification of chemotherapy by nitroimidazole. Int J Radiat Oncol Biol Phys 10: 1585–1594.

    Article  PubMed  CAS  Google Scholar 

  11. Siemann DW, Hill SA (1984) Enhanced tumour response through therapies combining CCNU, misonidazole and radiation. Int

    Google Scholar 

  12. J Radiat Oncol Biol Phys 10: 1623–1626.

    Google Scholar 

Manipulation of Tumour Oxygenation for a Therapeutic Advantage

  1. Adams GE, Barnes DWH, Du Boulay C, Loutit JF, Cole S, Sheldon P, Stratford IJ, van den Aardweg GJMJ, Hopewell JW, White RD, Kneen G, Nethersell AB, Edwards C (1986) Induction of hypoxia in normal and malignant tissues by changing the oxygen affinity of hemoglobin-Implications for therapy. Int J Radiat Oncol Biol Phys 12: 1299–1302.

    Article  PubMed  CAS  Google Scholar 

  2. Adams GE, Stratford IJ, Gooden J, Nowells N (1989) Effect of vasoactive agents on the effectiveness of electron affinic radiation sensitizers in vivo. Int J Radiation Oncol Biol Phys (In press).

    Google Scholar 

  3. Chaplin DJ, Acker B, Olive PL (1989) Potentiation of the tumour cytotoxicity of melphalan by vasoactive drugs. Int J Radiat Oncol Biol Phys 16: 1131–1136.

    Article  PubMed  CAS  Google Scholar 

  4. Hirst G, Wood PJ (1989) Chlorophenoxyacetic acid derivatives as hemoglobin modifiers and tumour oxygenator. Int J Radiat Oncol Biol Phys 16: 1183–1186.

    Article  PubMed  CAS  Google Scholar 

Hyporyradiothhrapy

  1. Balmukhanov SB, Turdugulov Z, Karibjanova Z, Revesz L (1982) The growth rate of bone marrow sarcoma and survival after radiotherapy with tourniquet-induced hypoxia. A clinical study. Cancer 49: 1597–1604.

    Google Scholar 

  2. Neumeister K, Revesz L (1987) Advances in hypoxyradiotherapy. Int J Radiat Oncol Biol Phys 13: 427–431.

    Article  PubMed  CAS  Google Scholar 

  3. Suit HD, Lindberg RS (1968) Radiation therapy administered under conditions of tourniquet-induced local tissue hypoxia. Amer J Roentgenol 102: 27–32.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. National Cancer Institute, University of Cairo, Cairo, Egypt

    Hassan K. Awwad

Authors
  1. Hassan K. Awwad
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 1990 Springer Science+Business Media Dordrecht

About this chapter

Cite this chapter

Awwad, H.K. (1990). Hypoxia in Solid Tumours and Normal Tissues: Clinical Implications. In: Radiation Oncology: Radiobiological and Physiological Perspectives. Developments in Oncology, vol 60. Springer, Dordrecht. https://doi.org/10.1007/978-94-015-7865-3_23

Download citation

  • DOI: https://doi.org/10.1007/978-94-015-7865-3_23

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-015-7867-7

  • Online ISBN: 978-94-015-7865-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation